Andy Lundin, Author at Hematology Advancements

Erythroferrone: A Breakthrough in Iron Regulation for Anemia Treatment

Posted by Andy Lundin | Jun 14, 2024 | Treatment Advances |

Erythroferrone shows promise as a treatment for anemia, particularly in chronic disease anemia and iron-refractory iron deficiency anemia.

Posted by Andy Lundin | Jun 13, 2024 | Innovations |

CRISPR-Cas9 technology is revolutionizing gene therapy for hematological disorders like sickle cell disease and beta-thalassemia.

Improving patient care in hematology practices involves enhancing communication and integrating advanced technologies.

Academic-industry partnerships accelerate hematology research, combining university expertise and pharmaceutical innovation.

Leveraging technologies like EHRs, telemedicine, and automated diagnostic tools for hematology clinics is key for operational efficiency.